neutral
antibodi
critic
compon
protect
recoveri
viral
infect
absenc
avail
vaccin
antivir
drug
mani
import
human
viral
pathogen
identif
character
new
human
monoclon
antibodi
hmab
abl
neutral
virus
offer
possibl
effect
preandor
postexposur
therapeut
modal
hmab
may
also
help
understand
viru
entri
process
mechan
viru
neutral
eventu
develop
specif
entri
inhibitor
vaccin
research
tool
major
recent
develop
antivir
hmab
come
use
antibodi
phagedisplay
technolog
use
immun
librari
mani
agent
also
envelop
virus
possess
import
neutral
determin
within
membraneanchor
envelop
glycoprotein
use
recombin
solubl
version
viral
glycoprotein
often
critic
isol
develop
antivir
hmab
chapter
detail
sever
method
success
employ
produc
purifi
character
solubl
secret
version
sever
viral
envelop
glycoprotein
success
use
antigen
captur
isol
human
phagedisplay
monoclon
antibodi
vast
major
viral
pathogen
pauciti
drugbas
therapi
rather
develop
vaccin
mainstay
prevent
intervent
strategi
combat
human
anim
viral
diseas
present
viral
vaccin
approv
human
use
exclud
variou
subtyp
major
liveattenu
formul
review
gener
term
liveattenu
viral
vaccin
highli
effect
elicit
balanc
immun
respons
recipi
host
stimul
cellmedi
humor
immun
howev
mani
virus
especi
associ
highli
pathogen
characterist
biolog
safeti
restrict
agent
retrovirus
human
immunodefici
viru
type
use
liveattenu
vaccin
feasibl
number
studi
demonstr
import
neutral
antibodi
protect
recoveri
viral
infect
inde
oblig
intracellular
parasit
virus
pose
signific
challeng
develop
effect
antivir
therapeut
neutral
polyclon
antibodi
long
histori
effect
virus
recent
monoclon
antibodi
mab
also
shown
success
human
mab
synagi
palivizumab
current
mab
viral
diseas
approv
us
food
drug
administr
fda
wide
use
prophylact
measur
respiratori
syncyti
viru
rsv
infect
neonat
immunecompromis
individu
costeffect
efficaci
origin
polyclon
product
recent
antirsv
palivizumab
improv
motavizumab
shown
potent
inhibit
viral
replic
upper
respiratori
tract
cotton
rat
model
virusneutr
antibodi
also
administ
passiv
acut
infect
individu
highli
efficaci
mechan
passiv
administ
antibodi
therapi
view
antivir
drug
suppress
infect
permit
host
mount
effect
immun
respons
today
passiv
administ
antibodi
routin
use
effect
antivir
therapi
prophylact
hepat
b
varicellazost
rabi
viru
measl
viru
other
review
case
use
firstlin
therapi
postexposur
measur
circumst
vaccin
possibl
howev
serum
polyclon
antibodi
prepar
associ
problem
relat
toxic
potenti
allerg
reaction
well
lottolot
variat
uncertain
dose
regim
major
advanc
further
develop
specif
mab
use
bacteri
phagedisplay
platform
combinatori
antibodi
librari
phage
librari
prepar
encod
human
antibodi
fab
contain
lightchain
first
two
domain
heavychain
singlechain
variabl
domain
fragment
scfv
contain
variabl
domain
light
heavi
chain
technolog
complement
innov
affin
matur
strategi
improv
antibodi
bind
review
techniqu
human
phagedisplay
antibodi
platform
facilit
rapid
identif
isol
specif
human
mab
elimin
immun
hybridoma
develop
human
process
absenc
avail
vaccin
antivir
drug
identif
character
new
human
monoclon
antibodi
hmab
abl
neutral
virus
offer
possibl
effect
preand
postexposur
therapeut
modal
antibodi
may
also
help
understand
viru
entri
process
underli
mechan
viral
neutral
mechan
eventu
develop
specif
entri
inhibitor
vaccin
research
tool
mani
recent
exampl
develop
isol
hmab
use
phagedisplay
methodolog
reactiv
import
human
viral
pathogen
includ
paramyxovirus
hendra
viru
hev
nipah
viru
niv
human
sar
coronaviru
mani
viral
pathogen
also
envelop
virus
almost
without
except
neutral
antibodi
envelop
virus
direct
viru
envelop
glycoprotein
tradit
antibodi
respons
immunolog
measur
vaccin
efficaci
known
viral
envelop
glycoprotein
homoor
heterooligom
matur
function
form
multimer
protein
like
gener
interact
larg
area
often
translat
import
structur
differ
monomer
subunit
matur
oligom
featur
also
impart
signific
differ
antigen
structur
shown
number
protein
trimer
influenza
ha
glycoprotein
addit
virus
pose
signific
addit
challeng
antigen
variat
structur
protein
import
neutral
determin
perhap
bestcharacter
exampl
particular
problem
primari
isol
exist
across
mani
vari
subtyp
effort
circumv
issu
improv
enhanc
techniqu
phagedisplay
antibodi
librari
pan
develop
order
better
select
broadli
reactiv
mab
mab
reactiv
particular
subunit
multisubunit
viral
glycoprotein
sequenti
antigen
pan
sap
competit
antigen
pan
cap
methodolog
often
critic
antigen
use
pan
isol
hmab
phage
librari
produc
andor
purifi
use
method
wherebi
retain
nearn
structur
conform
oligomer
configur
use
approach
develop
viral
membran
glycoprotein
suitabl
pan
phage
librari
antigen
elicit
antibodi
respons
recogn
nativ
form
engin
solubl
secret
version
molecul
often
approach
yield
quaternari
structur
similar
nativ
counterpart
anim
virus
eukaryot
express
system
typic
employ
recombin
bacculoviru
vaccinia
viru
transient
stabl
express
cell
cultur
chapter
detail
sever
method
success
employ
produc
purifi
character
solubl
secret
version
sever
viral
envelop
glycoprotein
success
use
antigen
captur
isol
human
phagedisplay
mab
method
describ
outlin
step
recombin
viral
glycoprotein
product
use
vaccinia
viru
hev
niv
solubl
g
glycoprotein
sg
affin
purif
glycoprotein
addit
recombin
viral
glycoprotein
product
affin
purif
stabl
hev
niv
solubl
f
glycoprotein
sf
secret
cell
line
detail
addit
purif
oligomer
analys
method
also
detail
includ
sizeexclus
gel
filtrat
sucros
gradient
ultracentrifug
analysi
blue
nativ
polyacrylamid
gel
electrophoresi
bnpage
analysi
design
construct
recombin
vaccinia
virus
encod
hev
niv
sg
well
character
recombin
solubl
secret
viral
glycoprotein
detail
elsewher
section
purpos
addit
illustr
emphasi
product
purif
solubl
secret
form
hev
niv
f
glycoprotein
includ
analysi
oligomer
characterist
well
gener
stabl
cell
line
secret
recombin
sf
add
ml
viru
inoculum
moi
bottl
gentli
roll
spread
inoculum
cell
monolay
immedi
add
addit
ml
optimem
roller
bottl
gentli
roll
spread
inoculum
cell
monolay
return
roller
bottl
incub
allow
infect
proceed
h
rpm
follow
incub
add
addit
ml
optimem
flow
roller
bottl
co
describ
section
step
incub
cell
incub
rpm
h
harvest
supernat
supernat
store
readi
affin
purif
recommend
process
supernat
soonest
possibl
first
step
purif
depend
protein
natur
tag
engin
protein
differ
approach
carri
affin
purif
describ
use
lentil
lectin
purif
highli
glycosyl
sprotein
agaros
purif
ntermin
speptidetag
hev
niv
sg
buffer
degass
sterilefilt
load
bed
volum
lentil
lectin
sepharos
tm
xk
column
allow
bead
settl
add
ethanol
cm
sepharos
surfac
push
column
inlet
adaptor
downward
tightli
contact
ethanol
leav
cm
ethanol
sepharos
surfac
column
inlet
avoid
format
air
bubbl
tighten
connect
via
ore
use
knob
top
column
inlet
adaptor
use
peristalt
pump
appli
buffer
input
tube
appli
prepar
supernat
section
column
use
peristalt
pump
maintain
constant
flow
rate
mlmin
save
flowthrough
purifi
protein
obtain
small
portion
ml
use
immunoprecipit
section
wash
column
ml
wash
buffer
follow
ml
wash
buffer
ii
remov
triton
elut
protein
appli
elut
buffer
column
stop
flow
first
ml
flowthrough
incub
min
collect
ml
elut
steril
tube
stop
flow
incub
min
repeat
elut
incub
time
collect
sever
elut
combin
eluat
concentr
less
ml
follow
buffer
exchang
protein
buffer
pb
use
centriprep
molecular
weight
cutoff
centrifug
filter
unit
filter
purifi
protein
low
proteinbind
syring
filter
membran
store
prewet
membran
protein
buffer
filter
regener
column
appli
ml
highph
buffer
follow
ml
lowph
buffer
column
repeat
step
two
time
last
lowph
wash
appli
regener
buffer
column
follow
ml
pb
final
appli
ml
etoh
column
store
bead
etoh
bead
reus
five
time
load
ml
bed
volum
sprotein
agaros
xk
column
alway
maintain
least
cm
buffer
surfac
agaros
allow
column
inlet
adaptor
cm
buffer
level
allow
input
buffer
enter
column
dropwis
use
peristalt
pump
appli
buffer
inlet
tube
solut
pass
column
outlet
depend
graviti
wash
column
bed
volum
pb
follow
bed
volum
wash
buffer
ii
refer
section
buffer
appli
prepar
supernat
section
column
maintain
flow
rate
mlmin
adjust
peristalt
pump
stopcock
connect
outlet
tube
column
wash
column
bed
volum
wash
buffer
follow
bed
volum
wash
buffer
ii
subsequ
bed
volum
pb
elut
bound
protein
stop
pump
allow
pb
drain
reach
surfac
bead
add
ml
elut
buffer
incub
elut
buffer
bead
min
collect
first
ml
flowthrough
still
pb
collect
ml
elut
steril
conic
centrifug
tube
contain
ml
neutral
buffer
check
ph
ph
strip
add
neutral
buffer
need
obtain
neutral
ph
repeat
elut
incub
time
wash
column
bed
volum
pb
follow
bed
volum
ethanol
store
bead
ethanol
bead
reus
five
time
combin
neutral
elut
first
ml
flowthrough
step
concentr
elut
less
ml
bufferexchang
elut
protein
buffer
pb
use
centriprep
molecular
weight
cutoff
centrifug
filter
unit
filter
purifi
protein
low
proteinbind
filter
membran
store
prewet
membran
protein
buffer
filter
hevniv
sf
sever
consider
may
requir
construct
express
plasmid
exampl
kozak
translat
initi
sequenc
atg
start
codon
proper
initi
translat
promoterenhanc
termin
sequenc
express
plasmid
employ
type
antibiot
select
cell
line
employ
codon
optim
viral
rna
sequenc
mutat
modif
amino
acid
sequenc
enhanc
express
secret
tag
requir
facilit
protein
purif
etc
sf
construct
describ
optim
base
concern
figur
show
diagram
construct
sf
gcn
vector
employ
promotermodifi
pcdna
hygro
enhanc
cmv
promot
import
phcmv
vector
allow
high
express
level
human
mous
codonoptim
sf
hygromycin
select
marker
allow
select
transfect
cell
resist
commonli
use
geneticin
antibiot
replac
ctermin
transmembran
cytoplasm
tail
domain
f
trimer
motif
allow
stabil
protein
trimer
structur
henc
enhanc
express
secret
protein
follow
speptid
facilit
purif
immunodetect
sf
sprotein
agaros
antispeptid
antibodi
factor
xa
cleavag
site
iegr
also
engin
upstream
speptid
tag
allow
remov
tag
enzymat
digest
standard
clone
procedur
employ
construct
plasmid
gener
stabl
cell
line
sever
optim
may
requir
obtain
best
express
level
investig
transient
express
use
variou
cell
line
obtain
best
result
describ
transient
transfect
sf
construct
cell
use
lipidbas
transfect
procedur
express
level
analyz
use
immunoor
affin
precipit
cell
lysat
supernat
follow
sdspage
western
blot
access
secret
level
best
express
construct
optim
best
cell
line
stabl
cell
line
gener
order
select
stabl
cell
clone
express
solubl
glycoprotein
minimum
concentr
appropri
select
antibiot
requir
kill
nontransfect
host
cell
line
need
determin
natur
resist
vari
among
cell
line
recommend
test
rang
antibiot
concentr
confluent
cell
choos
concentr
prevent
growth
within
day
kill
cell
within
day
procedur
describ
optim
cell
cell
remain
plate
cell
line
gener
add
ml
pb
wash
cell
without
disturb
monolay
remov
pb
add
ml
trypsinedta
allow
trypsin
aspir
trypsin
use
fresh
medium
resuspend
cell
transfer
cell
tissu
cultur
flask
add
ml
flask
allow
cell
adher
co
sever
hour
overnight
cell
adher
replac
medium
fresh
supplement
mgml
hygromycin
b
prepar
anoth
flask
select
medium
nontransfect
cell
monitor
action
antibiot
chang
replac
select
medium
necessari
observ
color
chang
medium
chang
medium
also
remov
dead
cell
nonexpress
cell
die
within
sever
day
express
coloni
start
form
cell
may
take
day
depend
transfect
effici
dead
cell
remov
coloni
grow
well
cell
transfer
tissu
cultur
flask
form
monolay
aspir
medium
flask
add
ml
pb
gentli
rock
flask
aspir
pb
cell
reach
confluenc
split
dilut
select
medium
repeat
anoth
two
passag
keep
ml
supernat
affin
precipit
monitor
secret
level
cell
reach
confluenc
third
passag
proceed
section
aspir
medium
flask
add
pb
gentli
rock
flask
aspir
pb
add
mlwell
dilut
cell
step
select
medium
inner
well
prepar
plate
step
well
less
one
cell
allow
coloni
form
co
day
observ
well
microscop
identifi
singlecoloni
well
day
color
medium
start
chang
transfer
singl
coloni
individu
pipet
plate
select
medium
ad
well
allow
monolay
form
co
day
cell
reach
confluenc
take
ml
supernat
well
immunoprecipit
western
blot
section
assess
strongest
secret
clone
replac
select
medium
plate
best
clone
determin
expand
larger
tissu
cultur
flask
aspir
medium
well
select
clone
add
ml
pb
add
ml
trypsinedta
remov
pb
allow
trypsin
remov
trypsin
resuspend
cell
ml
transfer
resuspend
cell
tissu
cultur
flask
ad
ml
select
medium
allow
cell
grow
confluenc
co
may
take
week
repeat
clone
step
least
ensur
stabl
express
obtain
best
possibl
secret
clone
desir
clone
obtain
expand
cell
larger
flask
freez
keep
stock
proceed
section
protein
express
stabl
cell
line
establish
grown
roller
bottl
largerscal
protein
product
follow
protocol
describ
largescal
product
secret
sf
cell
roller
bottl
protein
express
addit
select
antibiot
necessari
weak
adher
natur
deriv
cell
gelatin
treatment
roller
bottl
surfac
necessari
avoid
format
cell
clump
decreas
protein
secret
level
wash
cell
ml
pb
gentli
without
disturb
monolay
remov
pb
add
ml
optimem
pump
co
roller
bottl
describ
section
step
allow
protein
secret
day
cell
start
detach
harvest
supernat
describ
section
step
essenti
similar
section
except
replac
buffer
list
section
omit
pb
wash
step
protein
concentr
yield
estim
use
bradford
method
estim
protein
concentr
od
point
small
portion
purifi
protein
analyz
sdspage
follow
coomassi
stain
fig
proceed
section
molecular
weight
purif
follow
saffin
purif
concentr
purifi
protein
analyz
sdspage
follow
coomassi
stain
assess
puriti
yield
case
presenc
small
amount
contamin
protein
especi
purif
done
serum
medium
henc
purif
need
gel
filtrat
chromatographi
separ
molecul
basi
size
often
reserv
final
step
purif
achiev
higher
puriti
method
also
use
estim
molecular
mass
globular
protein
nativ
condit
base
migrat
chromatograph
matrix
pack
column
prepack
column
variou
matrix
differ
fraction
rang
avail
commerci
ge
healthcar
approxim
molecular
mass
certain
protein
estim
calibr
curv
obtain
seri
standard
protein
known
molecular
mass
standard
calibr
protein
kit
obtain
commerci
exampl
ge
healthcar
sigma
etc
welldescrib
calibr
protocol
molecular
weight
differ
oligomer
speci
determin
prepar
chromatographi
carri
isol
desir
oligomer
speci
describ
use
calibr
superdex
gl
gel
filtrat
column
estim
approxim
molecular
mass
differ
oligomer
speci
solubl
viral
glycoprotein
use
exampl
hev
niv
sf
gcn
also
describ
use
hiload
superdex
prep
grade
gel
filtrat
column
xk
separ
differ
oligomer
speci
affinitypurifi
sf
analyz
solubl
viral
glycoprotein
calibr
column
seri
protein
standard
superdex
gl
gel
filtrat
column
employ
calibr
molecular
weight
kda
calibr
kit
depict
fig
calibr
curv
gener
use
estim
approxim
size
hev
sf
gcn
welldescrib
calibr
protocol
includ
commerci
avail
gel
filtrat
molecular
weight
calibr
kit
simpl
procedur
use
determin
approxim
size
sf
inlet
tube
column
connect
appropri
buffer
pump
set
back
pressur
limit
mpa
connect
column
outlet
tube
optic
unit
flow
cell
uv
detector
wash
column
least
column
volum
ml
steril
deioniz
water
flow
rate
mlh
equilibr
column
appropri
protein
buffer
section
least
column
volum
flow
rate
set
sensit
ab
mg
sf
sg
ab
ml
recommend
concentr
protein
standard
exceed
mg
protein
ml
sampl
volum
appli
protein
standard
separ
run
set
baselin
uv
detector
set
chart
speed
cmh
proceed
next
step
sampl
applic
stabl
baselin
observ
stop
pump
disconnect
column
inlet
tube
pump
appli
affinitypurifi
protein
protein
standard
column
use
syring
reconnect
input
tube
pump
use
sampl
volum
protein
standard
unknown
sampl
stop
collect
last
peak
observ
wash
column
least
column
volum
steril
deioniz
water
follow
column
volum
ethanol
store
column
ethanol
obtain
elut
volum
v
e
measur
volum
eluent
point
sampl
applic
center
elut
peak
determin
void
volum
v
v
e
blue
dextran
mgml
calcul
k
av
valu
protein
use
formula
v
c
total
column
volum
gener
calibr
curv
plot
calcul
k
av
protein
standard
log
known
molecular
weight
calcul
estim
molecular
weight
solubl
viral
glycoprotein
calibr
curv
take
ml
fraction
peak
solubl
glycoprotein
nativ
gel
analysi
section
observ
oligomer
speci
figur
show
repres
result
pool
select
peak
fraction
concentr
ml
use
centriprep
molecular
weight
cutoff
centrifug
filter
unit
observ
mg
purifi
protein
nativ
gel
figur
show
purifi
hev
sf
gcn
trimer
nativ
gel
nativ
oligomer
form
purifi
solubl
glycoprotein
also
analyz
sucros
gradient
centrifug
shown
fig
two
speci
larg
aggreg
trimer
hev
sf
gcn
observ
sucros
gradient
consist
gel
filtrat
profil
shown
fig
collect
fraction
approxim
ml
bottom
gradient
use
beckman
fraction
recoveri
system
autom
fraction
collector
take
ml
fraction
nativ
gel
analysi
observ
oligomer
speci
nativ
gel
analysi
allow
visual
solubl
glycoprotein
polyacrylamid
gel
electrophoresi
nativ
form
allow
estim
size
nativ
oligomer
speci
help
analyz
fraction
separ
gel
filtrat
sucros
gradient
bn
gel
system
base
origin
describ
system
schagger
von
jagow
mani
modif
made
base
origin
method
exampl
observ
nativ
form
env
find
commerci
avail
bnpage
system
invitrogen
corp
suitabl
solubl
glycoprotein
analysi
requir
littl
optim
includ
welldescrib
stepbystep
protocol
bnpage
system
coomassi
bind
protein
confer
neg
charg
maintain
protein
nativ
state
procedur
use
analyz
solubl
glycoprotein
use
bnpage
system
follow
western
blot
ml
add
ml
nativepag
tm
sampl
buffer
ml
nativepag
tm
ml
protein
sampl
set
electrophoresi
system
use
nativepag
tm
novex
bistri
gel
mm
well
xcell
surelock
tm
minicel
describ
manufactur
rins
well
run
buffer
load
sampl
ad
cathod
buffer
load
ml
nativemark
tm
unstain
protein
standard
coomassi
stain
ml
ad
ml
western
blot
perform
electrophoresi
v
h
room
temperatur
cathod
buffer
stain
protein
electrophoresi
therefor
stain
requir
howev
depend
sensit
requir
sensit
stain
protocol
avail
manufactur
electrophoresi
place
gel
contain
fix
solut
enough
cover
gel
microwav
gel
nearboil
cool
min
orbit
shaker
tri
inhibitor
dtssp
crosslink
dtssp
use
protein
downstream
analysi
hepe
use
altern
neutral
buffer
arginin
prevent
protein
aggreg
use
protein
refold
also
help
elut
protein
antibodi
addit
arginin
option
find
necessari
sf
purif
cell
dens
estim
follow
day
incub
cell
growth
base
flask
contain
greater
cell
obtain
maximum
yield
pure
protein
cell
must
dens
seed
roller
bottl
infect
purifi
recombin
vaccinia
viru
ensur
cell
clump
broken
repeatedli
pipet
suspens
even
cell
suspens
necessari
even
monolay
roller
bottl
format
cell
clump
roller
bottl
decreas
protein
yield
pipett
without
cotton
stopper
connect
tube
connect
co
air
tank
pressur
control
indic
filter
membran
connect
tube
prewet
filter
unit
membran
pb
triton
appropri
wash
buffer
filter
supernat
done
filter
mll
wash
buffer
prior
sampl
filter
find
procedur
decreas
protein
lost
filtrat
step
essenti
purif
sf
gelatin
treatment
option
howev
deriv
cell
gelatintr
surfac
allow
cell
adher
better
mediumchang
procedur
transfect
henc
yield
better
transfect
result
coat
ml
per
well
steril
gelatin
onto
sixwel
tissu
cultur
plate
incub
plate
h
overnight
rins
twice
steril
pb
use
harvest
dmem
medium
follow
procedur
section
use
medium
scolumn
purif
describ
section
still
contamin
serum
protein
stage
appli
neutral
elut
anoth
round
scolumn
purif
smaller
scale
scale
buffer
ml
bed
volum
sagaros
use
ml
polyprep
chromatographi
column
biorad
laboratori
inc
flow
rate
entir
depend
graviti
depend
expect
protein
yield
sever
column
may
requir
estim
ml
bed
volum
sagaros
abl
captur
least
mg
sf
use
three
column
sf
gcn
mg
recov
supernat
ten
roller
bottl
